Advanced Medical Isotope Operating Income 2013-2024 | RDGL
Advanced Medical Isotope operating income from 2013 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| Advanced Medical Isotope Annual Operating Income (Millions of US $) |
|
|---|---|
| 2024 | $-3 |
| 2023 | $-3 |
| 2022 | $-3 |
| 2021 | $-3 |
| 2020 | $-1 |
| 2019 | $-1 |
| 2018 | $-2 |
| 2017 | $-3 |
| 2016 | $-4 |
| 2015 | $-2 |
| 2014 | $-2 |
| 2013 | $-4 |
| 2012 | $-6 |
| Advanced Medical Isotope Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2024-12-31 | $-1 |
| 2024-09-30 | $-1 |
| 2024-06-30 | $-1 |
| 2024-03-31 | $-1 |
| 2023-12-31 | $-1 |
| 2023-09-30 | $-1 |
| 2023-06-30 | $-1 |
| 2023-03-31 | $0 |
| 2022-12-31 | $-1 |
| 2022-09-30 | $0 |
| 2022-06-30 | $-1 |
| 2022-03-31 | $-1 |
| 2021-12-31 | $0 |
| 2021-09-30 | $0 |
| 2021-06-30 | $-2 |
| 2021-03-31 | $0 |
| 2020-12-31 | $0 |
| 2020-09-30 | $0 |
| 2020-06-30 | $0 |
| 2020-03-31 | $0 |
| 2019-12-31 | $0 |
| 2019-09-30 | $-1 |
| 2019-06-30 | $0 |
| 2019-03-31 | $0 |
| 2018-12-31 | $-2 |
| 2018-09-30 | $0 |
| 2018-06-30 | $0 |
| 2018-03-31 | $0 |
| 2017-12-31 | $-1 |
| 2017-09-30 | $-1 |
| 2017-06-30 | $-1 |
| 2017-03-31 | $0 |
| 2016-12-31 | $0 |
| 2016-09-30 | $-1 |
| 2016-06-30 | $-3 |
| 2016-03-31 | $-1 |
| 2015-12-31 | $-1 |
| 2015-09-30 | $0 |
| 2015-06-30 | $0 |
| 2015-03-31 | $0 |
| 2014-12-31 | $0 |
| 2014-09-30 | $0 |
| 2014-06-30 | $-1 |
| 2014-03-31 | $-1 |
| 2013-12-31 | $0 |
| 2013-09-30 | $0 |
| 2013-06-30 | $-1 |
| 2013-03-31 | $-1 |
| 2012-12-31 | $-2 |
| 2012-09-30 | $-2 |
| 2012-06-30 | $-1 |
| 2012-03-31 | $-1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Finance | FIN-SBIC&COMMRL | $0.068B | $0.000B |
| Vivos Inc. is a late stage development company. It engaged primarily in the development of brachytherapy devices for therapeutic applications. Vivos Inc., formerly known as Advanced Medical Isotope Corporation, is based in Richland, Washington. | |||